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ABSTRACT
Mgs1, the budding yeast homolog of mammalian
Werner helicase-interacting protein 1 (WRNIP1/
WHIP), contributes to genome stability during undis-
turbed replication and in response to DNA damage.
A ubiquitin-binding zinc finger (UBZ) domain directs
human WRNIP1 to nuclear foci, but the functional
significance of its presence and the relevant
ubiquitylation targets that this domain recognizes
have remained unknown. Here, we provide a mech-
anistic basis for the ubiquitin-binding properties of
the protein. We show that in yeast an analogous
domain exclusively mediates the damage-related
activities of Mgs1. By means of preferential physical
interactions with the ubiquitylated forms of the rep-
licative sliding clamp, proliferating cell nuclear
antigen (PCNA), the UBZ domain facilitates recruit-
ment of Mgs1 to sites of replication stress. Mgs1
appears to interfere with the function of polymerase
d, consistent with our observation that Mgs1 inhibits
the interaction between the polymerase and PCNA.
Our identification of Mgs1 as a UBZ-dependent
downstream effector of ubiquitylated PCNA
suggests an explanation for the ambivalent role of
the protein in damage processing.
INTRODUCTION
Post-translational modiﬁcation of a protein is an effective
strategy to modulate its activity or its interactions with
other cellular factors that selectively recognize the
protein in its modiﬁed form. Ubiquitin is a particularly
versatile modiﬁer, due to its ability to form polymeric
chains that can serve as a signal not only for
proteasome-mediated degradation, but also for a variety
of non-proteolytic events (1). Dedicated ubiquitin-binding
domains, which differ in their selectivity for
monoubiquitin or particular chain geometries, usually me-
diate the recognition of ubiquitylated target proteins by
downstream effectors (2).
One of the areas of cellular metabolism that is heavily
inﬂuenced by the ubiquitin system is the maintenance of
genome stability (3,4). Several pathways for the recogni-
tion, repair and bypass of DNA damage are controlled or
modulated by the ubiquitylation of key components, and
ubiquitin-binding domains have been identiﬁed within
relevant interaction partners (5). The RAD6 pathway, an
ensemble of ubiquitin conjugation enzymes (E2) and
ligases (E3), controls the replicative bypass of DNA
lesions through modiﬁcation of the eukaryotic sliding
clamp, proliferating cell nuclear antigen (PCNA) (in
yeast encoded by POL30). In response to DNA damage
or replication stress, PCNA is mono- and
polyubiquitylated at a highly conserved lysine (K)
residue, K164 (6), at sites where replication problems
have caused the accumulation of single-stranded (ss)
DNA (7–9). Monoubiquitylation is achieved by the E2
Rad6 in cooperation with the E3 Rad18, and
polyubiquitylation additionally involves the dimeric E2
complex Ubc13-Mms2 and the E3 Rad5 (6,10). While
monoubiquitylation of PCNA activates a series of
damage tolerant, highly mutagenic DNA polymerases
for bypass via translesion synthesis (TLS) (11–13),
polyubiquitylation is required for an error-free damage
avoidance pathway that probably involves template
switching to the undamaged sister chromatid (6,14). TLS
polymerases of the Y family, polymerases Z, k, i and
Rev1, harbour ubiquitin-binding domains of the UBZ or
UBM type, which mediate the recruitment to
ubiquitylated PCNA at sites of replication problems
(15,16). Ubiquitin-binding effector protein(s) that might
recognize polyubiquitylated PCNA and thereby mediate
error-free damage bypass are as yet unknown.
The RAD6 pathway operates in the context of other
systems for genome maintenance (17). One of these is rep-
resented by Mgs1, a DNA-dependent ATPase of the
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+ class (18). MGS1 from Saccharomyces cerevisiae
was ﬁrst identiﬁed as a gene contributing to the mainten-
ance of genome stability both during undisturbed replica-
tion and in response to DNA damage (18), whereas its
mammalian homolog, WRNIP1/WHIP, was independent-
ly discovered as an interactor of the Werner helicase,
WRN (19). Gene dosage appears to be critical for
MGS1 function, as both deletion and overexpression affect
recombination and mutation rates, and overexpression—
but not deletion—sensitizes cells to DNA-damaging
agents or replication problems (18,20). Genetic and
physical interactions have been observed with the poly-
merase d–PCNA complex in yeast (20–22), and mamma-
lian WRNIP1 was found to accumulate in PML bodies
and RPA-associated nuclear foci (23). Although no direct
effect of WRNIP1 on the WRN pathway was detected in
mammalian cells (24), yeast mgs1 mutants exhibit a syn-
thetic growth defect in combination with mutants of the
WRN homolog SGS1 (25). An impact on the RAD6
pathway was postulated based on physical interactions
between Mgs1 and PCNA and a synthetic lethality
between mgs1 and rad18 mutants that could be suppressed
by enhancing homologous recombination (21,26).
Recently, a ubiquitin-binding zinc ﬁnger (UBZ), related
to those present in polymerases Z and k and in Rad18, was
identiﬁed in mammalian WRNIP1 (23,27). We have now
investigated the contributions of this domain to Mgs1
activity in yeast and ﬁnd that UBZ-mediated binding of
the protein to ubiquitylated PCNA speciﬁcally mediates
the DNA damage-related functions of Mgs1. Physical
interactions with ubiquitylated PCNA and a modulatory
inﬂuence on the function of polymerase d in ubiquitin-
dependent DNA damage bypass implicate Mgs1 as a
downstream effector of the RAD6 pathway and provide
a functional link between an important ubiquitylation
target and a downstream effector that recognizes the
target in its modiﬁed form.
MATERIALS AND METHODS
Construction of yeast strains
Standard procedures were followed for growth and ma-
nipulation of Saccharomyces cerevisiae. All experiments
were performed with sets of isogenic strains, which were
derivatives of either DF5 (his1-1, leu2-3, 2-112, lys2-801,
trp1-1, ura3-52) or W303 (ade2-1, ura3-1, his3-11, 15,
trp1-1, leu2-3,112, can1-100), except for the isogenic
series of strains used for analysis of the pol31 (hys2-1)
mutant, a gift from D. Branzei (20) and originally
isolated by K. Sugimoto (ade1, his2, his3-D200, trp1,
ura3, leu2, hys2-1) and the strain used for two-hybrid
assays, PJ69-4A (trp1-901, leu2-3,112, ura3-52, his3-200,
gal4D, gal80D, LYS2::GAL1-HIS3, GAL2-ADE2,
met2::GAL7-lacZ). Mutants rad18, ubc13, pol30(K164R)
and tlsD have been described (12,28–30). Deletion of
MGS1, POL32 and SGS1 was accomplished by replace-
ment with a PCR-generated cassette bearing the URA3,
HisMX, KanMX or HphNT1 marker (31–33), and com-
binations of mutants were obtained by mating and tetrad
dissection or by successive gene deletions. For analysis of
spontaneous homologous recombination rates, diploid
strains heterozygous for the HIS1 gene (his1-1/his1-7)
were generated (34). The dna2D405N mutation (35) was
obtained by replacement of the open reading frame with
the N-terminally truncated allele in the genomic locus.
Strains pol3DCt (L1094stop) and pol2-11 (S2193stop)
(36) were constructed by introducing a PCR-generated
cassette appending a STOP codon followed by the
KanMX marker at the desired position. The pol30-79
mutant was obtained by transformation of WT cells
with the plasmid pBL230-79, a gift from P. Burgers, and
subsequent deletion of the endogenous POL30 as
described (37). Mutant pol32DPIP (38) was generated by
integration of the truncated allele, pol32(1-337),o na
plasmid under control of its own promoter, into a pol32
deletion. A
HisPOL30 derivative in pol32 was constructed
by replacement of the POL30 open reading frame with the
His-tagged allele, while in the pol31, pol2-11 and pol3DCt
backgrounds the tagged allele was introduced on an inte-
grative plasmid in addition to the endogenous POL30.
Alleles of MGS1 tagged with the 9myc-epitope were
generated by appending a PCR-generated cassette to the
open reading frame. For genetic analysis of complemen-
tation, relevant MGS1 alleles were introduced into mgs1
strains on integrative vectors under control of the MGS1
promoter. For overexpression, integrative vectors with the
GAL1 promoter or episomal vectors with the MGS1
promoter were used as indicated.
Construction of plasmids
Constructs encoding MGS1 and its mutants were
generated in YIplac128, YIplac204, YEplac195 (39) or
pRS424 (40) with the MGS1, GAL1 or ADH1 promoters,
and the empty vectors were used as controls. Two-hybrid
constructs were generated in pGAD424 or pGBT9
(Clontech) or derivatives thereof (41). Constructs for the
UBZ domain only spanned amino acids 1–47. The series
of plasmids encoding the linear ubiquitin–PCNA fusions
and the Ub*-GFP* control have been described (30,42).
Brieﬂy, the Ub*n constructs are head-to-tail fusions of
ubiquitin moieties carrying the mutations K29R, K48R,
K63R and G76V, while the Ub*n(L) series incorporates a
four-amino acid linker (VQIQ) between the ubiquitin
moieties. The POL30 open reading frame in the respective
PCNA* fusions bears the K127/164R mutations.
Constructs Smt3*–PCNA* and PCNA*–Smt3* were
created analogously. When used as C-terminal fusion
partners, both Ub* and Smt3* moieties carried deletions
of the two C-terminal glycine residues to prevent conjuga-
tion. For in vitro analysis, the Ub*n(L)–PCNA* fusions
were subcloned into pET28c (Novagen), incorporating an
N-terminal His6-tag, except for Ub*–PCNA* itself, which
was in pQE-32 (Qiagen). Constructs for expression of
GST-tagged proteins in Escherichia coli were created in
pGEX-4T-1 (GE Healthcare).
Genetic assays in yeast
For analyses involving Gal-MGS1 overexpression, cells
were pre-grown overnight at 30C in glycerol medium,
diluted into galactose or glucose medium and grown to
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microscopically by following the proliferation of 50 indi-
vidual newly budded daughter cells per strain and repeat-
edly dissecting away their daughter (43). Spontaneous
heteroallelic homologous recombination rates in the
HIS1 locus (20) were measured by ﬂuctuation analysis in
diploid mgs1/mgs1 cells complemented with two copies of
MGS1 or MGS1* as indicated. Brieﬂy, 11 cultures of the
respective diploids were grown in rich medium to a density
of 10
7cells/ml, and aliquots were plated onto rich
medium to determine total cell numbers and histidine-free
medium to determine the number of recombinants. Rates
and standard deviations were calculated according to the
method of the median (44). Damage-induced mutation
frequencies were measured in the CAN1 locus by
incubating the relevant strains in 0.1% methyl methane-
sulfonate (MMS) in either glucose or galactose medium
for 0–45min, inactivation of the drug by dilution into
10% sodium thiosulfate and plating onto medium with
and without 30mg/ml canavanine to determine the ratio
of can
R cells to survivors. Each value was averaged from
three independent cultures. Sensitivities to MMS were
compared by spotting series of 10-fold dilutions of
isogenic strains onto plates containing deﬁned concentra-
tions of the drug and recording growth after incubation
for 3days at 30C (or 25C for temperature-sensitive
mutants) (12). Temperature sensitivities were assessed
similarly by incubating the plates at differerent tempera-
tures, or by following the optical density (600nm) of ex-
ponentially growing liquid cultures.
Detection of PCNA modiﬁcations in vivo
HisPOL30 cultures were treated with 0.02% MMS for
60min, and ubiquitylation of PCNA was detected by de-
naturing Ni–NTA afﬁnity chromatography and western
blot with PCNA- and ubiquitin-speciﬁc antibodies as
described (7,28).
Preparation of recombinant proteins
Production of recombinant proteins was induced in E. coli
BL21 by addition of 0.1mMIPTG and incubation for 6–
8h at 37C. GST- and His6-tagged proteins were puriﬁed
by afﬁnity chromatography on glutathione Sepharose or
Ni–NTA resin, respectively, according to the manufactur-
er’s instructions. Puriﬁcation of untagged PCNA and the
components for its in vitro ubiquitylation have been
described (10). Human E1 was purchased from Biomol,
and ubiquitin and its derivatives were from Boston
Biochem.
Protein–protein interaction assays
Two-hybrid assays for detection of in vivo protein–protein
interactions were performed in the reporter strain PJ69-4A
as described (41), using fusions to the Gal4 activation
(AD) and DNA-binding (BD) domains. For three-hybrid
experiments, MGS1 and MGS1* were overexpressed
under control of the ADH1 promoter from an episomal
vector bearing the URA3 marker. In vitro interaction
assays were performed in phosphate-buffered saline with
0.05% Triton X-100 by immobilizing the relevant
GST-tagged protein on glutathione Sepharose for 1h at
4C, addition of the respective binding partner, further
incubation for 2h at 4C, washing four times with the
same buffer and eluting bound material by boiling in
SDS sample buffer before analysing the samples by SDS
gel electrophoresis and western blotting.
In vitro PCNA ubiquitylation
PCNA mono- and polyubiquitylation reactions were set
up in the presence of primed, RPA-coated X174 ssDNA
as described previously (10). Control reactions contained
PCNA, DNA, RPA and ATP and were incubated in the
presence or absence of the clamp loader, RFC, but
without ubiquitin conjugation factors. All reactions were
treated with Benzonase (Novagen) to degrade the DNA
before using them for GST pull-down assays.
Chromatin immunoprecipitations
Chromatin immunoprecipitation (ChIP) assays at an
early-ﬁring replication origin (ARS607) were performed
in cells treated with 100mMHU as described previously
(28). The late origin ARS501 served as negative control.
ChIP was performed from the same cultures with
antibodies against PCNA and myc, and the signal
relative to mock samples prepared without antibody was
quantiﬁed by real-time PCR. Signals were averaged from
two to three independent experiments.
RESULTS
DNA damage-related functions of Mgs1 require the UBZ
domain
Deletion of MGS1, but also its overexpression, causes
genome instability in budding yeast (18,20), and while
some of the phenotypes associated with non-physiological
protein levels are apparent in undamaged cells, others
become evident only after treatment with
DNA-damaging agents. In order to dissect the relevance
of ubiquitin binding for Mgs1 function, we systematically
analysed the contributions of its UBZ domain to a range
of reported phenotypes. A UBZ mutant (designated
MGS1*) was generated by changing an invariant aspartate
residue, D31, to alanine. Analogous mutations were pre-
viously shown to abolish mono- and polyubiquitin
binding in human WRNIP1 and human and yeast poly-
merase Z (15,23,27,42). An mgs1 deletion strain was com-
plemented with wild-type (WT) MGS1 or MGS1*a t
physiological levels in order to examine loss-of-function
phenotypes, and MGS1 or MGS1* expressed under
control of a galactose-inducible promoter or from a
multicopy vector were used to assess the consequences
of overexpression.
Inactivation of MGS1 causes a moderate reduction in
life span (19). While we were able to demonstrate this
ageing phenotype for the mgs1 deletion, mutation of the
UBZ domain had no adverse effect (Figure 1A). Likewise,
an elevated rate of spontaneous heteroallelic
interchromosomal recombination, observable in diploid
mgs1/mgs1 mutants (18,20), was not detectable in an
Nucleic AcidsResearch, 2012, Vol.40,No. 1 247MGS1*/MGS1* strain (Figure 1B). Finally, the MGS1*
allele was as efﬁcient as WT MGS1 in rescuing the syn-
thetic lethality of a rad18 mgs1 double mutant (26) (Figure
1C) and the slight synthetic growth defect of an sgs1 mgs1
strain (25) (Figure 1D), indicating that the UBZ domain
does not contribute to either of these aspects of MGS1
function.
Deletion of MGS1 does not result in a measurable DNA
damage sensitivity, but overexpression sensitizes cells
towards agents like ultraviolet (UV) radiation, MMS or
hydroxyurea (HU) and suppresses damage-induced muta-
genesis (18,20). We found that, in contrast to WT MGS1,
overexpression of MGS1* resulted in neither increased
sensitivity to MMS or HU nor suppression of induced
mutagenesis after MMS treatment (Figure 1E and F).
Protein levels of WT and mutant Mgs1 were indistinguish-
able (Supplementary Figure S1), indicating that a lack of
protein stability was not likely responsible for the
Figure 1. The UBZ domain is required speciﬁcally for the damage-related activities of Mgs1. (A) The UBZ domain is dispensable for longevity. Life
span analysis of WT cells in comparison with mgs1 deletion mutants alone or complemented with either MGS1 or the UBZ mutant (D31A) allele,
MGS1*, on an integrative plasmid under control of its own promoter. (B) The UBZ domain does not inﬂuence spontaneous recombination. Rates of
heteroallelic recombination in the HIS1 locus (his1-1/his1-7) in diploid mgs1/mgs1 cells complemented with two copies of MGS1 or MGS1* as
indicated. The empty vector served as control. Error bars indicate standard deviations. (C) The UBZ domain is irrelevant for the synthetic lethality
of rad18 mgs1 mutants. Shown are progeny of genetic crosses between rad18 and mgs1 mutants, each carrying an empty vector, MGS1 or MGS1* as
indicated. Tetrads are aligned in perpendicular orientation. (D) The UBZ domain is irrelevant for the synthetic growth defect of sgs1 mgs1 mutants.
Growth of the indicated strains on rich medium was monitored by spot assays. (E) Overexpression of MGS1 sensitizes cells to DNA damage and
replication problems in a UBZ-dependent manner. Spot assays for sensitivity to MMS and hydroxyurea (HU) at the indicated concentrations were
performed with WT cells carrying vectors for overexpression of MGS1 alleles under control of a galactose-inducible promoter (Gal-MGS1 and
Gal-MGS1*). The empty vector served as control. (F) Overexpression of MGS1 suppresses DNA damage-induced mutagenesis in a UBZ-dependent
manner. Frequencies of MMS-induced mutations in the CAN1 locus were determined for WT strains harbouring Gal-MGS1 or Gal-MGS1*. The
empty vector served as control. Error bars represent standard deviations from three independent measurements. (G) Suppression of the temperature
sensitivity of dna2D405N by overexpression of MGS1 requires catalytic activity, but not the UBZ domain. Overexpression was achieved by means of
episomal (2m) vectors with the MGS1 promoter. Growth at 25C and 37C was monitored by spot assays. (H) Inactivation of the Mgs1 UBZ
domain is sufﬁcient to suppress the damage sensitivity of pol32 mutants. Sensitivity of the indicated strains to MMS was assessed by spot assays.
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that the ATPase activity of Mgs1 is required for mediating
the effects caused by overexpression (18,20) suggested that
the negative consequences for damage resistance and
induced mutagenesis were due to a speciﬁc activity of
Mgs1 and not simply to abnormally high protein levels.
These results indicated that ubiquitin binding is
involved in some, but not all activities of Mgs1, but they
did not differentiate whether the UBZ domain speciﬁcally
affects damage-related functions or rather those that
require overexpression. This issue was addressed by
examining additional phenotypes that would uncouple
the two effects. On one hand, MGS1 overexpression has
previously been shown to suppress the temperature sensi-
tivity of a truncation mutant of DNA2, a nuclease/helicase
involved in Okazaki fragment processing (dna2D405N), in
a damage-independent fashion (35). Figure 1G shows that
MGS1*, in contrast to the catalytically inactive mutant
mgs1(K183A), was functional in this assay. On the
other hand, deletion of MGS1 is known to suppress the
DNA damage sensitivity of strains lacking the
non-essential subunit of polymerase d, Pol32 (20). In this
assay, inactivation of the UBZ domain had the same effect
as an mgs1 deletion (Figure 1H). Hence, the conditions
under which MGS1* exhibits defects correlate with the
presence of exogenous DNA damage, but not with
overexpression. Taken together, our data therefore
support the idea that ubiquitin binding is important for
those, and only those activities of Mgs1 related to the
presence of exogenous DNA damage.
DNA damage-related functions of Mgs1 require PCNA
ubiquitylation
Given that physical interactions between Mgs1 and PCNA
have been reported (21), and PCNA is ubiquitylated in
response to DNA damage, we asked whether the remark-
able damage dependence of the UBZ-associated Mgs1
activities was related to PCNA modiﬁcation. To address
this question, we examined the effect of MGS1 or MGS1*
overexpression in mutants defective in various aspects of
the RAD6 pathway. In pol30(K164R) and rad18 mutants,
which are both completely devoid of damage-dependent
PCNA ubiquitylation at K164 (6), the sensitization to
MMS by overexpression of MGS1 was no longer observed,
indicating that PCNA is indeed the ubiquitylation target
relevant for the UBZ-dependent functions of Mgs1
(Figure 2A). Neither selective abolishment of poly-
ubiquitylation (by deletion of UBC13) nor inactivation
of all three TLS polymerases (rad30 rev1 rev3, designated
as tlsD) was sufﬁcient to abrogate the sensitizing effect of
MGS1 overexpression, but the simultaneous inactivation
of UBC13 and the TLS polymerases resulted in a situation
comparable to the rad18 deletion (Figure 2B). Hence, the
negative action of MGS1 relies on a combined effect on
both branches of the RAD6 pathway.
These data are consistent with an action of Mgs1 either
on events downstream of PCNA ubiquitylation or on the
modiﬁcation reaction itself. Our observation that neither
deletion nor overexpression of MGS1 or MGS1* signiﬁ-
cantly affected damage-induced PCNA ubiquitylation
(Figure 2C) ruled out the latter scenario. Hence, Mgs1
appears to interfere with an aspect of DNA damage
bypass downstream of PCNA ubiquitylation.
Mgs1 preferentially interacts with polyubiquitylated
PCNA via the UBZ domain
The notion that PCNA ubiquitylation is required for the
damage- and UBZ-dependent activities of MGS1 strongly
suggested a physical interaction of the UBZ domain with
the ubiquitin moieties that are attached to PCNA in
response to DNA damage. We examined this possibility
in the two-hybrid system, using monoubiquitin and a
series of linear tandem arrays as mimics of polyubiquitin
chains, either free or fused to PCNA (30). Interactions
between Mgs1 and either unmodiﬁed PCNA or free
mono- or polyubiquitin were not observed in this assay,
indicating that these associations are too weak or transient
to be detected (Figure 3A). In contrast, monoubiquitin
fused to the N- or C-terminus of PCNA resulted in a
weak, but reproducible UBZ-dependent signal. The inter-
action was enhanced by increasing the number of ubiqui-
tin moieties to three or four, suggesting that Mgs1
preferentially interacts with polyubiquitylated PCNA
(Figure 3A). In contrast, PCNA fused to SUMO, or ubi-
quitin fused to an unrelated protein (GFP) did not interact
measurably with Mgs1. Likewise, the UBZ domain in iso-
lation did not bind any of the ubiquitin or PCNA con-
structs, indicating that a robust interaction requires the
association of Mgs1 with PCNA in combination with
UBZ-dependent binding of ubiquitin. Similar results
were obtained with two-hybrid constructs arranged in
the opposite orientation (Supplementary Figure S2A).
In order to conﬁrm that the observed interactions were
direct, we performed in vitro pull-down assays with puri-
ﬁed recombinant proteins (Figure 3B and Supplementary
Figure S2B). When assayed in isolation,
HisPCNA and the
linear ubiquitin–PCNA fusions all interacted efﬁciently
with immobilized
GSTMgs1. Under these conditions, the
isolated UBZ domain also bound polyubiquitin chains of
K48- and—with some preference—K63 linkage
(Supplementary Figure S2C), conﬁrming previous obser-
vations with mammalian WRNIP1 (23,27). However,
while
HisPCNA bound with comparable afﬁnity to
GSTMgs1 and
GSTMgs1*, interaction of the ubiquitin–
PCNA fusions with
GSTMgs1* was strongly reduced
(Figure 3B). It is possible that ubiquitin fused to the
N-terminus of PCNA interferes with binding to Mgs1
unless this effect is compensated by a productive ubiqui-
tin–UBZ association. Within an equimolar mixture of un-
modiﬁed
HisPCNA and the ubiquitin–PCNA fusions, a
clear preference of
GSTMgs1 for the tri- and tetraubiquitin
fusions was noted (Figure 3B, lane 3), conﬁrming our
two-hybrid data that implied a preferential interaction of
Mgs1 with polyubiquitylated PCNA. In contrast,
GSTMgs1* bound almost exclusively to unmodiﬁed
HisPCNA.
These data indicated that linear arrays of ubiquitin ef-
fectively mediate the UBZ-dependent enhancement of
Mgs1 binding to PCNA. However, we have previously
shown that these constructs do not perfectly mimic the
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PCNA in vivo (30). In order to conﬁrm our results with
physiologically K164-modiﬁed PCNA, in vitro mono- (M)
and polyubiquitylated (P) PCNA (10) was also examined
for binding to
GSTMgs1 or
GSTMgs1* (Figure 3C).
As expected, both
GSTMgs1 and
GSTMgs1* effectively
interacted with unmodiﬁed PCNA, while the
polyubiquitylated forms were enriched only by
GSTMgs1
and not by
GSTMgs1*, thus largely conﬁrming our results
with the linear ubiquitin–PCNA fusions.
Figure 2. Ubiquitylation of PCNA is required for the UBZ-dependent activity of Mgs1. (A) UBZ-dependent sensitization to DNA-damaging agents
by MGS1 overexpression requires PCNA ubiquitylation. MMS sensitivity assays were performed with the indicated strains harbouring Gal-MGS1 or
Gal-MGS1*, as described in Figure 1E. The empty vector served as control. (B) The effect of MGS1 overexpression on DNA damage sensitivity is
mediated by a combination of TLS and error-free damage bypass. MMS sensitivities upon MGS1 or MGS1* overexpression were assayed as in A in
strains lacking the capacity for either error-free damage bypass mediated by UBC13-dependent PCNA polyubiquitylation (ubc13)o r
monoubiquitin-dependent TLS by damage-tolerant polymerases (rad30 rev1 rev3, designated as tlsD), or both pathways. (C) MGS1 deletion or
overexpression does not affect PCNA ubiquitylation. Strains harbouring His6-tagged POL30 alleles and either an mgs1 deletion or the indicated
vectors were incubated with or without 0.02% MMS for 60min, and PCNA and its modiﬁed forms were isolated by Ni–NTA afﬁnity chromatog-
raphy under denaturing conditions and detected by western blotting.
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In order to determine whether the observed interaction of
Mgs1 with ubiquitylated PCNA was relevant in vivo,w e
performed ChIP assays on synchronized cultures to follow
the chromatin association of PCNA and Mgs1 at replica-
tion forks stalled by HU treatment. As shown previously
(28), PCNA, which becomes ubiquitylated under these
conditions, was readily detectable at an early replication
origin with a timing that reﬂects the slow movement of the
replication fork under these conditions (Figure 4A, left
panel). While the signal of Mgs1 expressed under
control of its endogenous promoter was insufﬁcient for
reliable detection (right panel), overexpression resulted
in a pattern very similar to that of PCNA (Figure 4B),
consistent with the recruitment of Mgs1 to those sites
where PCNA accumulates under conditions of replication
stress. A signiﬁcant reduction in the signal upon mutation
of either the UBZ domain of Mgs1 or the ubiquitin
acceptor site on PCNA indicated that efﬁcient Mgs1 as-
sociation required UBZ-mediated binding to
ubiquitylated PCNA (Figure 4C). The signal remaining
in Mgs1* and pol30(K164R) likely reﬂects the basal
afﬁnity of Mgs1 for unmodiﬁed PCNA (21). These
results suggest that ubiquitylation of PCNA contributes
to the UBZ-mediated recruitment of Mgs1 to stalled rep-
lication intermediates in vivo.
Mgs1 modulates the activity of polymerase d
The ubiquitin-mediated enhancement of the Mgs1–PCNA
interaction in response to DNA damage or replication
problems raised the question of what the function of
Mgs1 at replication forks is. The effects of MGS1
overexpression, such as the DNA damage sensitivity, the
suppression of damage-induced mutagenesis and the
rescue of the temperature sensitivity of the dna2D405N
mutant, strikingly resemble the phenotypes of a pol32
deletion (45–47), raising the possibility that Mgs1 inter-
feres with the function of this particular polymerase d
subunit. As shown in Figure 1H, however, deletion of
MGS1 suppresses the damage sensitivity of the pol32
deletion. This implies that Mgs1 has a negative activity
even in the absence of Pol32. We therefore examined the
effects of Mgs1 on other polymerase mutants with respect
to its UBZ domain. As with pol32, the damage sensitivities
of a truncation mutant of the catalytic polymerase d
subunit, pol3DCt (48), and a mutant allele of the essential
second-largest subunit, pol31 (hys2-1), were suppressed
by deletion of MGS1 or mutation of its UBZ domain
(Figure 5A and B). Surprisingly, MGS1* also suppressed
the temperature sensitivity of pol31 in the absence of ex-
ogenous DNA damage (Figure 5B). This was unexpected
Figure 3. Mgs1 preferentially interacts with ubiquitylated PCNA in a
UBZ-dependent manner. (A) Protein–protein interactions with
full-length Mgs1 and the isolated UBZ domain (amino acids 1–47)
were analysed in the two-hybrid system, using fusions to the Gal4 ac-
tivation (AD) and DNA-binding (BD) domains. Interactions were
tested with monoubiquitin (Ub*) and linear ubiquitin arrays (Ub*n)
either alone or fused to the N- or C-terminus of PCNA*. Asterisks
indicate mutations in PCNA and ubiquitin that prevent further modi-
ﬁcation and processing by isopeptidases, and ‘L’ signiﬁes a four-amino
acid linker. Fusions of Ub* to GFP and of Smt3 (G98V, to prevent
processing) to PCNA* were used as speciﬁcity controls. Empty vectors
(–) served as negative controls. Presence of the constructs was con-
ﬁrmed by growth on medium lacking leucine and tryptophan (-LW),
and positive signals were scored on medium additionally lacking histi-
dine (-HLW) or—for strong interactions—histidine and adenine
(-AHLW). (B) Interactions of Mgs1 with linear fusions of PCNA and
ubiquitin were analysed in vitro. GST-tagged versions of Mgs1 and
Mgs1* were immobilized on glutathione Sepharose and assayed for
binding to the puriﬁed Ub*n(L)–PCNA* constructs described in A,
produced as His6-tagged recombinant proteins, either in isolation or
as an equimolar mixture. An anti-GST control blot is shown in
Supplementary Figure S2B. (C) Interactions of Mgs1 were analysed
in vitro as in B, but using PCNA subjected to in vitro mono- (M) or
Figure 3. Continued
polyubiquitylation (P) at K164 prior to the assay. Unmodiﬁed PCNA
that was either left unloaded (–) or loaded (+) onto DNA in parallel
reactions served as controls. DNA was removed by nuclease treatment
before performing the pull-down assays. Asterisks on the blot indicate
cross-reactions of the anti-PCNA antibody with the GST fusion con-
structs. The bottom panel represents a weaker exposure of the blot.
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damage-related functions. We reasoned that the effect
might be due to a spontaneous ubiquitylation of PCNA
that is observable in a number of polymerase mutants
(49–51). Consistent with this notion, we found PCNA to
be constitutively ubiquitylated in pol31 as well as other
polymerase d mutants (Supplementary Figure S3A).
However, the polymerase e mutant pol2-11, which also
undergoes spontaneous PCNA ubiquitylation
(Supplementary Figure S3A), and also the tlsD mutant
remained unaffected by mgs1 or MGS1* (Supplementary
Figure S3B and C). Hence, the inhibitory action of Mgs1
is directed speciﬁcally at polymerase d, consistent with
previous ﬁndings indicating a dosage effect on polymerase
Figure 4. The UBZ domain contributes to the recruitment of Mgs1 to stalled replication intermediates. Association of Mgs1
9myc at an early
replication origin was monitored by ChIP and quantitative PCR. G1-arrested cells were released into the cell cycle in the presence of 100mM
hydroxyurea to slow the progression of replication forks and induce PCNA ubiquitylation, and association of Mgs1
9myc with an early-ﬁring rep-
lication origin (ARS607) was assessed at 10-min intervals (right panel). ChIP assays of PCNA from the same cultures served as a positive control for
a fork-associated protein (left panel), and ChIP assays at a late origin (ARS501) that does not ﬁre under these conditions served as a negative
control. Signals were quantiﬁed relative to background samples prepared without antibody. Error bars indicate standard deviations from two to three
experiments. (A) Mgs1 expressed at native levels is barely detectable by ChIP. Shown are signals of PCNA (left) and Mgs1
9myc (right) expressed at
physiological levels. (B) When overexpressed, Mgs1 is detectable at stalled replication intermediates. Shown are ChIP signals of PCNA (left) and
overexpressed Mgs1
9myc (right). (C) Mutating the UBZ domain of Mgs1 or the ubiquitylation site on PCNA reduces the association of Mgs1 with
replication intermediates. Shown are the ChIP signals of PCNA and Mgs1
9myc in the indicated strains at ARS607. The signals at ARS501 are omitted
for clarity.
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polymerase d was further supported by a severe
damage-independent growth inhibition conferred on
pol3DCt by overexpression of MGS1 or MGS1*, but
not the catalytically inactive mutant mgs1(K183A)
(Figure 5C). A similar effect was also observed in a
pol32(DPIP) mutant, encoding a protein that lacks the
C-terminal PCNA interaction motif (38), and—reciprocal-
ly—in pol30-79, which expresses a mutant of PCNA de-
fective in polymerase d interaction (37) (Figure 5D). As
before, overexpression of mgs1(K183R) had no inﬂuence
on the growth rates of the host strains (data not shown),
indicating that catalytic activity of Mgs1 was required for
the effect.
Taken together, these data illustrate an overall negative
impact of Mgs1 speciﬁcally on polymerase d that becomes
manifest in a dosage-dependent manner: on one hand, WT
cells are affected only by elevated Mgs1 levels under con-
ditions of DNA damage, when the protein is recruited to
sites of replication problems via UBZ-dependent binding
to ubiquitylated PCNA and appears to interfere with
damage processing. On the other hand, cells with com-
promised polymerase d activity are rendered damage- or
temperature sensitive by physiological levels of Mgs1,
while elevated levels now become inhibitory to growth
even under permissive conditions. At these high concen-
trations only, Mgs1’s toxic effect in the mutant strains no
longer requires the UBZ domain.
Mgs1 competes with polymerase d for interaction with
PCNA
The notion that Mgs1 interacts with and is recruited to
PCNA suggested that its impact on polymerase d might be
due to competitive physical interactions. We therefore
examined the effect of Mgs1 on the association between
PCNA and the polymerase d subunits Pol32, which is
known to make direct contacts with PCNA (38). As the
Pol32–PCNA interaction is detectable by two-hybrid
analysis, we monitored the consequences of over-
expressing MGS1 in this system (Figure 6). Consistent
with a competition between Pol32 and Mgs1 for PCNA
binding, overexpression of MGS1 or MGS1* slightly
reduced the signal corresponding to the Pol32–PCNA
interaction. The inhibitory effect of MGS1 on the inter-
action of Pol32 with a monoubiquitin–PCNA fusion,
Ub*–PCNA*, was considerably stronger, and in the case
of the tetraubiquitin–PCNA fusion, Ub*4–PCNA*, the
signal was virtually abolished. In contrast, overexpression
of MGS1* had no additional effect on the interactions of
the ubiquitin fusions with Pol32, consistent with the
UBZ-dependent enhancement of Mgs1’s afﬁnity for
PCNA by ubiquitylation of the clamp. Importantly,
MGS1 overexpression did not disturb the interaction of
PCNA or ubiquitin–PCNA fusions with polymerase Z,
which by itself gains additional afﬁnity for the
ubiquitylated forms of the clamp through a UBZ
domain (Supplementary Figure S4) (15).
DISCUSSION
Mgs1 as an interactor of polyubiquitylated PCNA
The data presented above indicate clear functional and
physical interactions of the Mgs1 UBZ domain with ubi-
quitin conjugated to PCNA upon exposure to replication
stress or DNA damage. In combination with a basal
afﬁnity of Mgs1 for PCNA itself (21), the UBZ domain
Figure 5. Mgs1 negatively acts on Polymerase d and PCNA. (A)
Deletion of MGS1 or inactivation of its UBZ domain suppresses the
damage sensitivity of pol3DCt. MMS sensitivities were determined by
spot assays in the indicated strains. (B) Deletion of MGS1 or inactiva-
tion of its UBZ domain suppresses the temperature and damage sensi-
tivity of a pol31 (hys2-1) mutant. Spot assays were performed as above
either on MMS-containing plates or by incubation at the indicated
temperatures. (C) Overexpression of MGS1 inhibits growth of the
pol3DCt mutant in a UBZ-independent manner. Growth of the
indicated cultures in rich medium at 30C was recorded by following
optical densities at 600nm. (D) Overexpression of MGS1 inhibits
growth of mutants with defective PCNA–Pol32 interactions in a
UBZ-independent manner. Growth of the indicated strains was moni-
tored by spot assays on rich medium at 30C.
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enhancer’, similar to other ubiquitin-binding domains that
mediate the recognition of relevant modiﬁed cellular
targets (2). In this way, the protein is directed towards
the replication fork in a damage-dependent manner,
with PCNA ubiquitylation serving as the critical event
controlling Mgs1 levels at the site of action.
Consistent with the requirements for target selectivity,
we found the binding of the UBZ domain to free ubiquitin
or ubiquitin chains to be weak and detectable only in vitro,
thus minimizing in vivo interactions with ubiquitin species
not conjugated to PCNA. Perhaps surprisingly, however,
Mgs1 appears to exhibit some preference for poly-
ubiquitylated over monoubiquitylated PCNA. This effect
was apparent in the two-hybrid and pull-down experi-
ments (Figure 3), but also in the genetic assays where
deleting UBC13 had a stronger effect than inactivating
TLS (Figure 2B). Given that UBZ domains tend to
recognize single ubiquitin moieties (2), the preference of
Mgs1 for polyubiquitylated PCNA may well be due to the
proposed multimeric structure of the protein (52) that
might result in a spatial arrangement of multiple UBZ
domains conducive to oligoubiquitin binding. Indeed, ac-
cumulation of WRNIP1 in nuclear foci was found to
depend on its oligomerization domain as well as the
UBZ domain (23). In addition, Crosetto et al. found
that the ubiquitin-binding domain derived from human
Rad18, but not those from TLS polymerases Z or i were
capable of substituting for the UBZ domain of WRNIP1,
which is surprising in light of the ability of the polymer-
ases, but not Rad18, to recognize ubiquitylated PCNA.
While it was concluded from these data that a speciﬁc
subtype of UBZ domain was required for correct
localization of the protein, our results suggest that con-
formational or steric characteristics rather than the type of
ubiquitin-binding domain may have been responsible for
the lack of the WRNIP1 chimeras to localize correctly.
Our identiﬁcation of Mgs1 as the ﬁrst protein reported
to interact preferentially with polyubiquitylated PCNA
raises the question of whether Mgs1 is indeed a
mediator of error-free damage bypass.
Mgs1 as a downstream effector of the RAD6 pathway
Given that—in contrast to UBC13—deletion of MGS1
does not result in DNA damage sensitivity, Mgs1 is
unlikely to act as the sole effector of polyubiquitylated
PCNA in vivo. Instead, the genetic data described here
and elsewhere (18,20,21) may even suggest a function as
a negative regulator of DNA damage bypass. In fact, it
was previously proposed that Mgs1 might inhibit the
RAD6 pathway in the absence of damage by interfer-
ing with PCNA ubiquitylation (21). While our results
(Figure 2C) clearly rule out this scenario, we cannot
exclude that Mgs1 interferes with an event downstream
of the modiﬁcation reaction. However, for the following
reasons we favour the idea that Mgs1 acts in a more
subtle, regulatory fashion on damage processing: ﬁrst,
Mgs1 promotes rather than interferes with overall genome
stability. Second, its inhibitory effects are apparent only at
non-physiological expression levels or in genetic back-
grounds with impaired polymerase activity, indicating that
appropriate protein levels are critical for correct Mgs1
function. It is therefore conceivable that Mgs1 might
affect the kinetics or timing of damage bypass in a way
that we are unable to resolve with currently available
methodology. Alternatively, Mgs1 may be redundant
with another, yet to be identiﬁed factor downstream of
ubiquitylated PCNA. Either scenario raises the question
of what the molecular mechanism of Mgs1 action is.
Mgs1 as a UBZ-controlled modulator of polymerase d
In a model that takes into account the physical inter-
actions of Mgs1, the importance of protein levels as well
as the negative effects on polymerase d mutants, we
envision Mgs1 as a ‘mobilizer’ for polymerase d at the
replication fork. By directly interfering with the PCNA–
polymerase d interaction, Mgs1 might facilitate release of
the polymerase during a variety of DNA transactions,
such as the polymerase switch associated with TLS, but
also the events preceding strand exchange in preparation
for template switching or other modes of replication
restart that Mgs1 has been implicated in (20,26). In the
context of damage bypass, where Mgs1 might facilitate or
Figure 6. Mgs1 competes with Pol32 for PCNA binding in the three-hybrid system. Fusions of the Gal4 activating domain to PCNA*, Ub*–PCNA*
or Ub*4–PCNA* (as indicated above the panels) were combined with fusions of the DNA-binding domain to Pol32 as described in Figure 3A, and
the effect of overexpressing MGS1 or MGS1* was assessed by spot assays, using 10-fold dilutions of three independent cultures per strain. An empty
vector served as control. Uracil was omitted from the plates to maintain the additional plasmid (-LWU, -HLWU).
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would be targeted to relevant sites by means of its
UBZ-dependent interaction with ubiquitylated PCNA.
In damage-unrelated situations, alternative, UBZ-
independent targeting mechanisms might apply. This
model offers an explanation for why excessive amounts
of Mgs1 are detrimental for damage bypass, and why
even physiological levels of the protein can interfere with
replication of undamaged templates in mutants that are
sensitized towards its actions through impaired polymer-
ase d function. Due to its modulatory function, loss of
Mgs1 alone would not cause major defects, but its bene-
ﬁcial actions on genome stability become obvious and
result in synergistic effects when other pathways of
damage processing are compromised, for example in
RAD6 pathway mutants (26) or in cells deﬁcient in
SGS1 (19,25) or mammalian BLM (53).
Unresolved questions
Our identiﬁcation of the UBZ domain as a targeting
module within Mgs1 provides an explanation for the
dual action of the protein in damage-dependent versus -
independent DNA transactions and places Mgs1 among
the other reported PCNA effectors that react to modiﬁca-
tions of the clamp, such as the TLS polymerases (15), the
anti-recombinogenic helicase Srs2 (28,54) and the alterna-
tive clamp loader subunit Elg1 (55,56).
In contrast to its recruitment mechanism, Mgs1’s exact
mode of action still remains an open question. Our results
suggest a competition between Mgs1 and polymerase d for
PCNA binding, but as Mgs1 has also been reported to
associate with polymerase d itself (22,25), the observed
effect might be due to an interaction of Mgs1 with either
PCNA or the polymerase or both. Based on the notion
that fusion of ubiquitin to PCNA enhanced the competi-
tive advantage of Mgs1 with respect to Pol32, we favour
the ﬁrst option, but further insight will have to come from
biochemical experiments addressing the interactions in the
context of DNA and the role of Mgs1’s ATPase activity in
the process.
Independently, the Mgs1 ATPase activity in combin-
ation with the UBZ domain had been postulated to play
a role in the metabolism of ubiquitylated proteins related
to that of the AAA
+ ATPase Cdc48 (27). This model is
based on experiments showing a reduced turnover of ubi-
quitin conjugates in mgs1 mutants, leading to a
hyperresistance to the translation inhibitor cycloheximide.
We have been unable to reproduce this effect in two dif-
ferent strain backgrounds (Supplementary Figure S5), and
our data strongly suggest a function of the UBZ domain
speciﬁcally in the recognition of ubiquitylated PCNA
rather than a general action on bulk ubiquitin conjugates.
Clearly, a biochemical characterization of the protein is
needed to relate the nature of its ATPase activity to its
biological function in vivo. In the context of DNA damage
bypass, however, we are only beginning to understand the
reactions following PCNA modiﬁcation, and insight into
the molecular mechanism of Mgs1 activity should there-
fore help us better understand the events involved in the
replication of damaged DNA.
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